NEW YORK (GenomeWeb News) – The Flanders government has extended a grant to Peakadilly to speed up development of its biomarker discovery platform, the Belgian company said today.
The company plans to use the funds, which total €1.7 million ($2.2 million), to expand relationships with pharma and diagnostic companies and to accelerate development of its own diagnostic products.
Peakadilly's biomarker discovery platform is based on its MASStermind techonology, which includes mass spectrometry techniques and data interpretation methods.
The Institute for the Promotion of Innovation by Science and Technology in Flanders made the grant extension.
In August, Peakadilly raised $10.9 million in venture capital funding.